BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Monica B. Pagano, William Hobbs, Michael Linenberger, Meghan Delaney. Plasma and red cell exchange transfusions for erythropoietic protoporphyria: A case report and review of the literatureJournal of Clinical Apheresis 2012; 27(6): 336 doi: 10.1002/jca.21249
2
H. Kadara, G. Nemer, R. Safi, N. Rebeiz, L. Daou, D. Delbani, W. Btadini, O. Abbas, M. Tofaili, F. Bitar, A.G. Kibbi, Y. Shimomura, M. Kurban. Erythropoietic protoporphyria a clinical and molecular study from Lebanon: Ferrochelatase a potential tumor suppressor gene in colon cancerClinical Genetics 2017; 92(5): 495 doi: 10.1111/cge.12968
3
Annika L. Windon, Rashmi Tondon, Nathan Singh, Samir Abu-Gazala, David L. Porter, J. Eric Russell, Colleen Cook, Elaine Lander, Georgeine Smith, Kim M. Olthoff, Abraham Shaked, Maarouf Hoteit, Emma E. Furth, Marina Serper. Erythropoietic protoporphyria in an adult with sequential liver and hematopoietic stem cell transplantation: A case reportAmerican Journal of Transplantation 2018; 18(3): 745 doi: 10.1111/ajt.14581
4
Tina S. Ipe, Huy P. Pham, Lance A. Williams. Critical updates in the 7th edition of the American Society for Apheresis guidelinesJournal of Clinical Apheresis 2018; 33(1): 78 doi: 10.1002/jca.21562
5
Dhiman Maitra, Eric L. Carter, Rani Richardson, Laure Rittié, Venkatesha Basrur, Haoming Zhang, Alexey I. Nesvizhskii, Yoichi Osawa, Matthew W. Wolf, Stephen W. Ragsdale, Nicolai Lehnert, Harald Herrmann, M. Bishr Omary. Oxygen and Conformation Dependent Protein Oxidation and Aggregation by Porphyrins in Hepatocytes and Light-Exposed CellsCellular and Molecular Gastroenterology and Hepatology 2019;  doi: 10.1016/j.jcmgh.2019.05.010
6
Graham Thom, Minh Lam, Michaela Lucas, Enrico Rossi. Leukocytoclastic vasculitis masking chronic vascular changes in previously undiagnosed erythropoietic protoporphyriaJournal of Cutaneous Pathology 2013; 40(11): 966 doi: 10.1111/cup.12215
7
M. Sachar, K. E. Anderson, X. Ma. Protoporphyrin IX: the Good, the Bad, and the UglyJournal of Pharmacology and Experimental Therapeutics 2016; 356(2): 267 doi: 10.1124/jpet.115.228130
8
Anthony Bonavia, Justin Pachuski, Dmitri Bezinover. Perioperative Anesthetic Management of Patients Having Liver Transplantation for Uncommon ConditionsSeminars in Cardiothoracic and Vascular Anesthesia 2018; 22(2): 197 doi: 10.1177/1089253217732129
9
Yuanfu Lu, Xue-Mei Zhao, Zhaoyong Hu, Li Wang, Feng Li. LC–MS-Based Metabolomics in the Study of Drug-Induced Liver InjuryCurrent Pharmacology Reports 2019; 5(1): 56 doi: 10.1007/s40495-018-0144-3
10
Yin Xiong, Yupiao Hu, Lijuan Chen, Zejun Zhang, Yiming Zhang, Ming Niu, Xiuming Cui. Unveiling Active Constituents and Potential Targets Related to the Hematinic Effect of Steamed Panax notoginseng Using Network Pharmacology Coupled With Multivariate Data AnalysesFrontiers in Pharmacology 2019; 9 doi: 10.3389/fphar.2018.01514
11
Amika Singla, David S. Moons, Natasha T. Snider, Elizabeth R. Wagenmaker, V. Bernadene Jayasundera, M. Bishr Omary. Oxidative stress, Nrf2 and keratin up-regulation associate with Mallory-Denk body formation in mouse erythropoietic protoporphyriaHepatology 2012; 56(1): 322 doi: 10.1002/hep.25664
12
Richard G. Standerwick, Edwin H.K. Yen, Benjamin Pliska. Orthodontic treatment considerations for a patient with erythropoietic protoporphyriaAmerican Journal of Orthodontics and Dentofacial Orthopedics 2013; 144(6): 899 doi: 10.1016/j.ajodo.2013.02.032
13
Pengcheng Wang, Madhav Sachar, Grace L. Guo, Amina I. Shehu, Jie Lu, Xiao-bo Zhong, Xiaochao Ma. Liver metabolomics in a mouse model of erythropoietic protoporphyriaBiochemical Pharmacology 2018; 154: 474 doi: 10.1016/j.bcp.2018.06.011
14
M. Biewenga, R.H.S. Matawlie, E.C.H. Friesema, H. Koole-Lesuis, M. Langeveld, J.H.P. Wilson, J.G. Langendonk. Osteoporosis in patients with erythropoietic protoporphyriaBritish Journal of Dermatology 2017; 177(6): 1693 doi: 10.1111/bjd.15893
15
Madhav Sachar, Feng Li, Ke Liu, Pengcheng Wang, Jie Lu, Xiaochao Ma. Chronic Treatment with Isoniazid Causes Protoporphyrin IX Accumulation in Mouse LiverChemical Research in Toxicology 2016; 29(8): 1293 doi: 10.1021/acs.chemrestox.6b00121
16
Moriyasu Anai, Shiho Miyase, Keiko Ishinuki, Natsumi Tsukano, Hirofumi Iwashita, Takaaki Ito, Shigetoshi Fujiyama. A case of erythropoietic protoporphyria with severe liver damageKanzo 2016; 57(5): 227 doi: 10.2957/kanzo.57.227
17
Takuya Nakamura, Jun Inoue, Takayuki Kogure, Eiji Kakazu, Masashi Ninomiya, Tatsuki Morosawa, Teruyuki Umetsu, Satoshi Takai, Hajime Nakano, Tooru Shimosegawa. A case of erythropoietic protoporphyria who was diagnosed genetically and whose serial liver specimens showed significant progression of fibrosisKanzo 2017; 58(5): 289 doi: 10.2957/kanzo.58.289
18
Sathidpak Nantasanti, Mathilda J. M. Toussaint, Sameh A. Youssef, Peter C. J. Tooten, Alain de Bruin, Matias A Avila. Rb and p53 Liver Functions Are Essential for Xenobiotic Metabolism and Tumor SuppressionPLOS ONE 2016; 11(3): e0150064 doi: 10.1371/journal.pone.0150064
19
Debby Wensink, Margreet AEM Wagenmakers, JH Paul Wilson, Janneke G Langendonk. Letter to the editor: Diagnosis of erythropoietic protoporphyria with severe liver injury - a case reportWorld Journal of Gastroenterology 2019; 25(30): 4292-4293 doi: 10.3748/wjg.v25.i30.4292
20
Makiko Yasuda, Robert J. Desnick. Murine models of the human porphyrias: Contributions toward understanding disease pathogenesis and the development of new therapiesMolecular Genetics and Metabolism 2019;  doi: 10.1016/j.ymgme.2019.01.007
21
Zhang-biao Long, Yong-wei Wang, Chen Yang, Gang Liu, Ya-li Du, Guang-jun Nie, Yan-zhong Chang, Bing Han. Identification of FECH gene multiple variations in two Chinese patients with erythropoietic protoporphyria and a reviewJournal of Zhejiang University-SCIENCE B 2016; 17(10): 813 doi: 10.1631/jzus.B1600085
22
Joana Rigor, Sara Almeida Pinto, Daniela Martins-Mendes. Porphyrias: A clinically based approachEuropean Journal of Internal Medicine 2019; 67: 24 doi: 10.1016/j.ejim.2019.06.014
23
Nikolaus Bresgen, Peter Eckl. Oxidative Stress and the Homeodynamics of Iron MetabolismBiomolecules 2015; 5(2): 808 doi: 10.3390/biom5020808
24
Joseph Schwartz, Anand Padmanabhan, Nicole Aqui, Rasheed A. Balogun, Laura Connelly-Smith, Meghan Delaney, Nancy M. Dunbar, Volker Witt, Yanyun Wu, Beth H. Shaz. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special IssueJournal of Clinical Apheresis 2016; 31(3): 149 doi: 10.1002/jca.21470
25
Dhiman Maitra, Jared S. Elenbaas, Steven E. Whitesall, Venkatesha Basrur, Louis G. D'Alecy, M. Bishr Omary. Ambient Light Promotes Selective Subcellular Proteotoxicity after Endogenous and Exogenous Porphyrinogenic StressJournal of Biological Chemistry 2015; 290(39): 23711 doi: 10.1074/jbc.M114.636001
26
Madhav Sachar, Xiaochao Ma. Role of ABCG2 in liver injury associated with erythropoietic protoporphyriaHepatology 2016; 64(1): 305 doi: 10.1002/hep.28249
27
Ulrich Stölzel, Manfred O. Doss, Detlef Schuppan. Clinical Guide and Update on PorphyriasGastroenterology 2019; 157(2): 365 doi: 10.1053/j.gastro.2019.04.050
28
Anand Padmanabhan, Laura Connelly‐Smith, Nicole Aqui, Rasheed A. Balogun, Reinhard Klingel, Erin Meyer, Huy P. Pham, Jennifer Schneiderman, Volker Witt, Yanyun Wu, Nicole D. Zantek, Nancy M. Dunbar, Guest Editor: Joseph Schwartz. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special IssueJournal of Clinical Apheresis 2019; 34(3): 171 doi: 10.1002/jca.21705
29
Laura Peltola, Derek Amoako. Hepatectomy in a patient with Erythropoietic ProtoporphyriaAnaesthesia Cases 2017; 5(2): 42 doi: 10.21466/ac.HIAPWEP.2017
30
Feng Li, Jie Lu, Jie Cheng, Laiyou Wang, Tsutomu Matsubara, Iván L Csanaky, Curtis D Klaassen, Frank J Gonzalez, Xiaochao Ma. Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapyNature Medicine 2013; 19(4): 418 doi: 10.1038/nm.3104
31
Uma Alagappan, Zacharias A. D. Pramono, Wei-Sheng Chong. Ferrochelatase gene mutation in Singapore and a novel frame-shift mutation in an Asian boy with erythropoietic protoporphyriaInternational Journal of Dermatology 2017; 56(3): 272 doi: 10.1111/ijd.13418
32
Dhiman Maitra, Juliana Bragazzi Cunha, Jared S. Elenbaas, Herbert L. Bonkovsky, Jordan A. Shavit, M. Bishr Omary. Porphyrin-Induced Protein Oxidation and Aggregation as a Mechanism of Porphyria-Associated Cell InjuryCellular and Molecular Gastroenterology and Hepatology 2019; 8(4): 535 doi: 10.1016/j.jcmgh.2019.06.006
33
C. Valiente Rebull, T. Moreno, R. Giardina, B. di Martino Ortiz. Protoporfiria eritropoyética. Comunicación de un caso con clínica dermatológica exuberantePiel 2015; 30(5): 330 doi: 10.1016/j.piel.2014.09.015
34
Jingheng Wu, Sixiang Wen, Yiwei Zhou, Hui Chao, Yong Shen. Human Ferrochelatase: Insights for the Mechanism of Ferrous Iron Approaching Protoporphyrin IX by QM/MM and QTCP Free Energy StudiesJournal of Chemical Information and Modeling 2016; 56(12): 2421 doi: 10.1021/acs.jcim.6b00216
35
Herbert L. Bonkovsky, Jun-Tao Guo, Weihong Hou, Ting Li, Tarun Narang, Manish Thapar. Comprehensive Physiology2013;  doi: 10.1002/cphy.c120006
36
Satoru Hagiwara, Naoshi Nishida, Masatoshi Kudo. ReplyHepatology 2016; 64(1): 306 doi: 10.1002/hep.28248
37
Leiyan He, Yaoxue Guo, Ye Deng, Chun Li, Chengzi Zuo, Wenxing Peng. Involvement of protoporphyrin IX accumulation in the pathogenesis of isoniazid/rifampicin-induced liver injury: the prevention of curcuminXenobiotica 2017; 47(2): 154 doi: 10.3109/00498254.2016.1160159
38
A Novel FECH Mutation Causes Erythropoietic Protoporphyria with Severe Liver DysfunctionHepatitis Monthly  doi: 10.5812/hepatmon.80767
39
Joseph Schwartz, Anand Padmanabhan, Nicole Aqui, Rasheed A. Balogun, Laura Connelly-Smith, Meghan Delaney, Nancy M. Dunbar, Volker Witt, Yanyun Wu, Beth H. Shaz. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special IssueJournal of Clinical Apheresis 2016; 31(3): 149 doi: 10.1002/jca.21470